Skip to main content
Log in

Preoperative C-Reactive Protein Level Adjusted for Comorbidities and Lifestyle Factors Predicts Overall Mortality in Localized Renal Cell Carcinoma

  • Original Research Article
  • Published:
Molecular Diagnosis & Therapy Aims and scope Submit manuscript

Abstract

Purpose: C-reactive protein (CRP), an acute phase reactant, is a non-specific marker of inflammation. Elevations in CRP levels are linked with trauma, infection, autoimmune disease, malignancy, and lifestyle factors, such as smoking and obesity. Previously, we noted a significant association between the preoperative CRP level, 1-year relapse-free survival, and 1-year overall relative survival in patients with localized renal cell carcinoma (RCC). This study sought to determine what effect, if any, lifestyle factors have on the prognostic value of preoperative CRP level for overall survival in individuals with localized RCC.

Methods: 257 patients with localized RCC who underwent nephrectomy were included in the study. Patients were enrolled between November 2006 and February 2010. The impact of tumor characteristics, lifestyle factors, and preoperative CRP level on overall survival was assessed through univariate and multivariate analyses.

Results: During the study, 15.2% of patients died. Univariate analysis found that tumor size (p < 0.001), tumor stage (p < 0.001), Fuhrman nuclear grade (p < 0.001), Charlson Comorbidity Index score (p < 0.001), smoking status (p = 0.038), and preoperative CRP level (p < 0.001) were significantly associated with overall survival. Only the preoperative CRP level (odds ratio 1.035; 95% confidence interval 1.007, 1.064) remained significantly associated with overall survival upon multivariate analysis.

Conclusions: Prognostic tools serve an important role in cancer management. Thirty percent of patients with localized RCC ultimately develop metastatic disease despite having potentially curative nephrectomy. Previous research has identified the preoperative CRP level as a significant predictor of overall survival in patients with localized RCC. This study demonstrated that the CRP level remained a robust predictive tool when the analysis was controlled for lifestyle factors, including smoking and obesity. Consequently, clinicians should consider taking preoperative CRP levels into account when treating patients with localized RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Fig. 1
Table II

Similar content being viewed by others

References

  1. Ramsey S, Lamb GW, Aitchison M, et al. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. BJU Int 2008; 101: 959–63

    Article  PubMed  CAS  Google Scholar 

  2. Iimura Y, Saito K, Fujii Y, et al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol 2009; 181: 1004–12; discussion 1012

    Article  PubMed  Google Scholar 

  3. Klatte T, Lam JS, Shuch B, et al. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol 2008; 26: 550–4

    Article  PubMed  Google Scholar 

  4. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007; 17: 303–8

    Article  PubMed  Google Scholar 

  5. Kavolius JP, Mastorakos DP, Pavlovich C, et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16: 2261–6

    PubMed  CAS  Google Scholar 

  6. Karakiewicz PI, Hutterer GC, Trinh QD, et al. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer 2007; 110: 1241–7

    Article  PubMed  CAS  Google Scholar 

  7. Lamb GW, McArdle PA, Ramsey S, et al. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int 2008; 102: 756–61

    Article  PubMed  Google Scholar 

  8. Jabs WJ, Busse M, Kruger S, et al. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int 2005; 68: 2103–10

    Article  PubMed  CAS  Google Scholar 

  9. Canna K, McMillan DC, McKee RF, et al. Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer. Br J Cancer 2004; 90: 1707–9

    PubMed  CAS  Google Scholar 

  10. McKeown DJ, Brown DJ, Kelly A, et al. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer 2004; 91: 1993–5

    Article  PubMed  CAS  Google Scholar 

  11. Johnson TV, Abbasi A, Owen-Smith A, et al. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. J Urol 2010; 183: 480–5

    Article  PubMed  CAS  Google Scholar 

  12. Reichert V, Xue X, Bartscherer D, et al. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 2009; 136: 212–9

    Article  PubMed  CAS  Google Scholar 

  13. Ray KK, Cannon CP, Cairns R, et al. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46: 1417–24

    Article  PubMed  CAS  Google Scholar 

  14. Ikonomidis I, Lekakis J, Vamvakou G, et al. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J 2005; 149: 832–9

    Article  PubMed  CAS  Google Scholar 

  15. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999; 84: 1018–22

    Article  PubMed  CAS  Google Scholar 

  16. Balagopal P, George D, Patton N, et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005; 146: 342–8

    Article  PubMed  Google Scholar 

  17. Villareal DT, Miller 3rd BV, Banks M, et al. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr 2006; 84: 1317–23

    PubMed  CAS  Google Scholar 

  18. Nicholls SJ, Tuzcu EM, Sipahi I, et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL study). Am J Cardiol 2006; 97: 1553–7

    Article  PubMed  CAS  Google Scholar 

  19. Master VA, Johnson TV, Abbasi A, et al. Poorly numerate patients in an inner city hospital misunderstand the American Urological Association symptom score. Urology 2010; 75: 148–52

    Article  PubMed  Google Scholar 

  20. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803–4

    Article  PubMed  CAS  Google Scholar 

  21. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655–63

    Article  PubMed  CAS  Google Scholar 

  22. Johnson TV, Abbasi A, Owen-Smith A, et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology 2010; 76: 766. e1–5

    CAS  Google Scholar 

  23. Johnson TV, Young AN, Osunkoya AO, et al. C-reactive protein as a clinically useful biomarker of metastasis of renal cell carcinoma. Mol Diagn Ther 2010; 14: 191–3

    Article  PubMed  Google Scholar 

  24. Richards CH, Leitch EF, Horgan PG, et al. The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer 2010; 103: 1356–61

    Article  PubMed  CAS  Google Scholar 

  25. Roxburgh CS, Platt JJ, Leitch EF, et al. Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer. Ann Surg Oncol 2011; 18: 997–1005

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No funding was received for the conduct of this study or the preparation of this manuscript. The authors have no conflicts of interest that are directly or indirectly related to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Viraj A. Master MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michigan, A., Johnson, T.V. & Master, V.A. Preoperative C-Reactive Protein Level Adjusted for Comorbidities and Lifestyle Factors Predicts Overall Mortality in Localized Renal Cell Carcinoma. Mol Diag Ther 15, 229–234 (2011). https://doi.org/10.1007/BF03256414

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256414

Keywords

Navigation